Sir, I am staunch follower of yours and dr. Benjamin bikman.I read your 2 books obesity code and reversing diabetes. Sir, you raised valid point ethical principles has to be followed. Hope people would understand. Ire
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @CMAJ: New research in CMAJ reveals undisclosed financial conflicts of interest in organizations that produce Canadian clinical guidelin…
RT @CMAJ: New research in CMAJ reveals undisclosed financial conflicts of interest in organizations that produce Canadian clinical guidelin…
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry. htt…
RT @CMAJ: New research in CMAJ reveals undisclosed financial conflicts of interest in organizations that produce Canadian clinical guidelin…
RT @eturnermd1: "Most Canadian national CPGs on the use of drugs are produced by disease or condition interest groups and medical professio…
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @eturnermd1: "Most Canadian national CPGs on the use of drugs are produced by disease or condition interest groups and medical professio…
RT @eturnermd1: "Most Canadian national CPGs on the use of drugs are produced by disease or condition interest groups and medical professio…
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry. htt…
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @eturnermd1: "Most Canadian national CPGs on the use of drugs are produced by disease or condition interest groups and medical professio…
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @CMAJ: New research in CMAJ reveals undisclosed financial conflicts of interest in organizations that produce Canadian clinical guidelin…
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry. htt…
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
What about the UK Organisations @DrAseemMalhotra has been warning us about.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry. htt…
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry. htt…
RT @CMAJ: New research in CMAJ reveals undisclosed financial conflicts of interest in organizations that produce Canadian clinical guidelin…
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @eturnermd1: "Most Canadian national CPGs on the use of drugs are produced by disease or condition interest groups and medical professio…
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry. htt…
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @eturnermd1: "Most Canadian national CPGs on the use of drugs are produced by disease or condition interest groups and medical professio…
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
No surprise there, and the rest?
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry. htt…
RT @eturnermd1: "Most Canadian national CPGs on the use of drugs are produced by disease or condition interest groups and medical professio…
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry. htt…
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @CMAJ: New research in CMAJ reveals undisclosed financial conflicts of interest in organizations that produce Canadian clinical guidelin…
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry. htt…
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry. htt…
RT @drjasonfung: Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
Sad, but not unexpected. Canadian guideline writers mostly choose not to disclose they take lots of $$$ from industry.
RT @CMAJ: New research in CMAJ reveals undisclosed financial conflicts of interest in organizations that produce Canadian clinical guidelin…
RT @eturnermd1: "Most Canadian national CPGs on the use of drugs are produced by disease or condition interest groups and medical professio…
RT @CMAJ: New research in CMAJ reveals undisclosed financial conflicts of interest in organizations that produce Canadian clinical guidelin…
RT @ATricco: Conflicts of interest exist in Canadian guidelines - study using the @SPORAlliance clinical practice guideline asset map https…
RT @PabloRichly: Es difícil encontrar un guía médica sin conflictos de intereses con la industria. https://t.co/pbtQ1339D7
Es difícil encontrar un guía médica sin conflictos de intereses con la industria. https://t.co/pbtQ1339D7
RT @eturnermd1: "Most Canadian national CPGs on the use of drugs are produced by disease or condition interest groups and medical professio…
RT @CMAJ: New research in CMAJ reveals undisclosed financial conflicts of interest in organizations that produce Canadian clinical guidelin…
RT @eturnermd1: "Most Canadian national CPGs on the use of drugs are produced by disease or condition interest groups and medical professio…
RT @eturnermd1: "Most Canadian national CPGs on the use of drugs are produced by disease or condition interest groups and medical professio…
"Most Canadian national CPGs on the use of drugs are produced by disease or condition interest groups and medical professional societies that receive funding from pharmaceutical companies with a direct interest in the drugs under consideration." cc co-aut
RT @AllenFrancesMD: Guidelines greatly influence diagnosis/testing/treatment- but too often deeply flawed by 3 conflicts of interest: 1)Fin…
RT @CMAJ: New research in CMAJ reveals undisclosed financial conflicts of interest in organizations that produce Canadian clinical guidelin…
RT @CMAJ: New research in CMAJ reveals undisclosed financial conflicts of interest in organizations that produce Canadian clinical guidelin…
RT @christine_fahim: Important study highlights COI in Canadian clinical practice guidelines and presents action-oriented solutions
Guidelines greatly influence diagnosis/testing/treatment- but too often deeply flawed by 3 conflicts of interest: 1)Financial- Pharma payoff/Guild interest 2)Intellectual- Experts know research/not practice 3)Emotional- Makers love their pets A new study:
RT @ATricco: Conflicts of interest exist in Canadian guidelines - study using the @SPORAlliance clinical practice guideline asset map https…
RT @ATricco: Conflicts of interest exist in Canadian guidelines - study using the @SPORAlliance clinical practice guideline asset map https…
RT @christine_fahim: Important study highlights COI in Canadian clinical practice guidelines and presents action-oriented solutions
RT @ATricco: Conflicts of interest exist in Canadian guidelines - study using the @SPORAlliance clinical practice guideline asset map https…
RT @christine_fahim: Important study highlights COI in Canadian clinical practice guidelines and presents action-oriented solutions
RT @ATricco: Conflicts of interest exist in Canadian guidelines - study using the @SPORAlliance clinical practice guideline asset map https…
Important study highlights COI in Canadian clinical practice guidelines and presents action-oriented solutions
RT @ATricco: Conflicts of interest exist in Canadian guidelines - study using the @SPORAlliance clinical practice guideline asset map https…
RT @ATricco: Conflicts of interest exist in Canadian guidelines - study using the @SPORAlliance clinical practice guideline asset map https…
Conflicts of interest exist in Canadian guidelines - study using the @SPORAlliance clinical practice guideline asset map https://t.co/1VUXNZhNCI
RT @HengartnerMP: Massive links to industry in producers of clinical practice guidelines - all financial conflicts of interest undeclared.…
RT @BJWilson059: Now as much as ever we need guidelines we can trust. @cantaskforce
RT @HengartnerMP: Massive links to industry in producers of clinical practice guidelines - all financial conflicts of interest undeclared.…
RT @HengartnerMP: Massive links to industry in producers of clinical practice guidelines - all financial conflicts of interest undeclared.…
RT @HengartnerMP: Massive links to industry in producers of clinical practice guidelines - all financial conflicts of interest undeclared.…
Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: a descriptive study https://t.co/iMeI5AauBY
RT @HengartnerMP: Massive links to industry in producers of clinical practice guidelines - all financial conflicts of interest undeclared.…
RT @HengartnerMP: Massive links to industry in producers of clinical practice guidelines - all financial conflicts of interest undeclared.…
Homimis Dignitati
RT @HengartnerMP: Massive links to industry in producers of clinical practice guidelines - all financial conflicts of interest undeclared.…
RT @DrNancyOlivieri: Needs to change: #MDs who recommend (in “guidelines") drugs prescribed to CDNs paid by #BigPharma, including the compa…
RT @DrNancyOlivieri: Needs to change: #MDs who recommend (in “guidelines") drugs prescribed to CDNs paid by #BigPharma, including the compa…
https://t.co/1A2Gghlb5U That the knowledge to practice gap (K2PG) averages ~17yrs doesn’t help matters. #mentalhealth care continues to resist the global paradigm shift that’s been underway for yrs. Willful blindness is enabled by these & other factors
There are 4 primary agendas in Canadian health care: professional, political, corporate, patient care. Way too often patient care is in 4th place under professional + corporate, and our publicly funded system means political is also too often prioritized o